Product Description: Antitumor agent-176 (Compound 22), an antitumor agent, can effectively bind to FGF2 and inhibit the activation of fibroblast growth factor receptor (FGFR) in multiple myeloma (MM) cells, exhibiting significant antitumor activity both in vivo and in vitro against MM[1].
Applications: Cancer-Kinase/protease
Formula: C21H16F6O3
References: [1]Taranto S, et al. Discovery of novel FGF trap small molecules endowed with anti-myeloma activity[J]. Pharmacological Research, 2024: 107291.
Molecular Weight: 430.34
Research Area: Cancer
Target: FGFR